Trial Profile
Randomized controlled trial of nucleoside in the treatment for postoperative primary liver cancer.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 May 2012
Price :
$35
*
At a glance
- Drugs Adefovir dipivoxil (Primary) ; Lamivudine (Primary) ; Adefovir; Antivirals
- Indications Hepatitis B
- Focus Therapeutic Use
- 21 May 2012 Actual end date changed from (Mar 2007) to (31 Mar 2008) added as reported by Chinese Clinical Trial Register record.
- 03 Oct 2009 New trial record